Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
ddp modified	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher	pref label
tabling member	label

Search

78512

	human indexable
	published
	registered interest
	answer date	21/07/2014
	date	16/07/2014
	date tabled	16/07/2014
	ddp created	16/07/2014 22:11:44
	ddp modified	07/02/2015 18:12:38
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Osteoarthritis
	house id	1
	identifier	206190
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	22/07/2014 13:39:02
	question text	To ask the Secretary of State for Health, how many people have suffered complications following knee and hip operations related to osteoarthritis in the last five years.
	session	2014/15
	session number	4
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	title	House of Commons Tabled Parliamentary Question 2014/15 206190
	type	WrittenParliamentaryQuestion
	uin	206190
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4034 label Biography information for Yvonne Fovargue
	publisher	25259 pref label House of Commons
	tabling member	4034 label Biography information for Yvonne Fovargue

90496

	human indexable
	published
	registered interest
	answer date	05/09/2014
	date	03/09/2014
	date tabled	03/09/2014
	ddp created	03/09/2014 21:31:02
	ddp modified	07/02/2015 21:25:05
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	identifier	208035
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	10/09/2014 12:18:26
	question text	To ask the Secretary of State for Health, what the next step is in the commissioning of a specialised service after a positive recommendation by the Prescribed Specialised Services Advisory Group (PSSAG); whether services recommended for commissioning by PSSAG in September 2014 will be funded from April 2015; when the PSSAG recommendations on the application for a specialised service for Alpha-1 Antitrypsin Deficiency will be published; and if he will make a statement.
	session	2014/15
	session number	4
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	title	House of Commons Tabled Parliamentary Question 2014/15 208035
	type	WrittenParliamentaryQuestion
	uin	208035
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4034 label Biography information for Yvonne Fovargue
	publisher	25259 pref label House of Commons
	tabling member	4034 label Biography information for Yvonne Fovargue

147552

	human indexable
	published
	registered interest
	answer date	17/11/2014
	date	10/11/2014
	date tabled	10/11/2014
	ddp created	11/11/2014 10:36:28
	ddp modified	08/02/2015 08:03:58
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Breast Cancer
	house id	1
	identifier	213933
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	20/11/2014 16:45:59
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure that (a) NHS England continues to routinely assess the quality and safety of local breast cancer multi-disciplinary teams and network groups as part of the National Cancer Peer Review programme and (b) this information is made available to patients through the My Cancer Treatment website.
	session	2014/15
	session number	4
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	title	House of Commons Tabled Parliamentary Question 2014/15 213933
	type	WrittenParliamentaryQuestion
	uin	213933
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	3924 label Biography information for Yasmin Qureshi
	publisher	25259 pref label House of Commons
	tabling member	3924 label Biography information for Yasmin Qureshi

147553

	human indexable
	published
	registered interest
	answer date	17/11/2014
	date	10/11/2014
	date tabled	10/11/2014
	ddp created	11/11/2014 10:36:28
	ddp modified	08/02/2015 08:04:04
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Drugs
	house id	1
	identifier	213936
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	19/11/2014 15:55:55
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure routine access to tamoxifen and raloxifene for the indication of chemoprevention in the UK.
	session	2014/15
	session number	4
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	title	House of Commons Tabled Parliamentary Question 2014/15 213936
	type	WrittenParliamentaryQuestion
	uin	213936
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	3924 label Biography information for Yasmin Qureshi
	publisher	25259 pref label House of Commons
	tabling member	3924 label Biography information for Yasmin Qureshi

147554

	human indexable
	published
	registered interest
	answer date	17/11/2014
	date	10/11/2014
	date tabled	10/11/2014
	ddp created	11/11/2014 10:36:29
	ddp modified	08/02/2015 08:04:14
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Drugs
	house id	1
	identifier	213934
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	19/11/2014 15:55:55
	question text	To ask the Secretary of State for Health, what proportion of women who are eligible for tamoxifen and raloxifene are offered this treatment.
	session	2014/15
	session number	4
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	title	House of Commons Tabled Parliamentary Question 2014/15 213934
	type	WrittenParliamentaryQuestion
	uin	213934
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	3924 label Biography information for Yasmin Qureshi
	publisher	25259 pref label House of Commons
	tabling member	3924 label Biography information for Yasmin Qureshi

147559

	human indexable
	published
	registered interest
	answer date	17/11/2014
	date	10/11/2014
	date tabled	10/11/2014
	ddp created	11/11/2014 10:36:32
	ddp modified	08/02/2015 08:04:43
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Drugs
	house id	1
	identifier	214030
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	19/11/2014 16:02:12
	question text	To ask the Secretary of State for Health, if he will take steps to ensure that clinically-proven, cost-effective drugs are made routinely available to all when they are shown to be of use in a new indication but are off-patent.
	session	2014/15
	session number	4
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	title	House of Commons Tabled Parliamentary Question 2014/15 214030
	type	WrittenParliamentaryQuestion
	uin	214030
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	3924 label Biography information for Yasmin Qureshi
	publisher	25259 pref label House of Commons
	tabling member	3924 label Biography information for Yasmin Qureshi

155393

	human indexable
	published
	registered interest
	answer date	17/11/2014
	date	11/11/2014
	date tabled	11/11/2014
	ddp created	11/11/2014 22:30:39
	ddp modified	08/02/2015 08:17:12
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pregnancy Tests
	house id	1
	identifier	214308
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	21/11/2014 14:26:47
	question text	To ask the Secretary of State for Health, when the Independent Panel on Hormone Pregnancy Tests will be set up; and what time frame he has set for that inquiry.
	session	2014/15
	session number	4
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	title	House of Commons Tabled Parliamentary Question 2014/15 214308
	type	WrittenParliamentaryQuestion
	uin	214308
	version	2
	written parliamentary question type	Ordinary
	answer	answer
	creator	3924 label Biography information for Yasmin Qureshi
	publisher	25259 pref label House of Commons
	tabling member	3924 label Biography information for Yasmin Qureshi

155394

	human indexable
	published
	registered interest
	answer date	17/11/2014
	date	11/11/2014
	date tabled	11/11/2014
	ddp created	11/11/2014 22:30:40
	ddp modified	08/02/2015 08:17:18
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pregnancy Tests
	house id	1
	identifier	214307
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	21/11/2014 14:26:46
	question text	To ask the Secretary of State for Health, what recent steps he has taken to ensure the impartiality and neutrality of members of the panel on hormone pregnancy tests.
	session	2014/15
	session number	4
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	title	House of Commons Tabled Parliamentary Question 2014/15 214307
	type	WrittenParliamentaryQuestion
	uin	214307
	version	2
	written parliamentary question type	Ordinary
	answer	answer
	creator	3924 label Biography information for Yasmin Qureshi
	publisher	25259 pref label House of Commons
	tabling member	3924 label Biography information for Yasmin Qureshi

155499

	human indexable
	published
	registered interest
	answer date	17/11/2014
	date	11/11/2014
	date tabled	11/11/2014
	ddp created	11/11/2014 22:31:45
	ddp modified	08/02/2015 08:28:45
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer
	house id	1
	identifier	214306
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	21/11/2014 14:24:34
	question text	To ask the Secretary of State for Health, what assessment he has made of the benefits to the gathering of data on local cancer service standards of the National Cancer Peer Review programme.
	session	2014/15
	session number	4
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	title	House of Commons Tabled Parliamentary Question 2014/15 214306
	type	WrittenParliamentaryQuestion
	uin	214306
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	3924 label Biography information for Yasmin Qureshi
	publisher	25259 pref label House of Commons
	tabling member	3924 label Biography information for Yasmin Qureshi

156996

	human indexable
	published
	registered interest
	answer date	25/11/2014
	date	20/11/2014
	date tabled	20/11/2014
	ddp created	20/11/2014 20:11:21
	ddp modified	08/02/2015 10:43:29
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dialysis Machines
	house id	1
	identifier	215402
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	25/11/2014 17:14:11
	question text	To ask the Secretary of State for Health, what steps NHS England has taken to ensure a safe transition of responsibility for dialysis commissioning to clinical commissioning groups from April 2015.
	session	2014/15
	session number	4
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	title	House of Commons Tabled Parliamentary Question 2014/15 215402
	type	WrittenParliamentaryQuestion
	uin	215402
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	3924 label Biography information for Yasmin Qureshi
	publisher	25259 pref label House of Commons
	tabling member	3924 label Biography information for Yasmin Qureshi